Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Bartee

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Oncolytic Virotherapy|March 6, 2018
Potential of oncolytic viruses in the treatment of multiple myelomaEric Bartee
Cytokine|July 31, 2009
Human cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-betaEric Bartee, Grant McFadden
Experimental Hematology & Oncology|May 27, 2017
In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockadeEric Bartee, Zihai Li
Cytokine|May 23, 2013
Cytokine synergy: an underappreciated contributor to innate anti-viral immunityEric Bartee, Grant McFadden
Molecular Therapy Oncolytics|January 1, 2020
Syncytia Formation in Oncolytic VirotherapyChase Burton, Eric Bartee
Journal for Immunotherapy of Cancer|April 13, 2022
The use of oncolytic virotherapy in the neoadjuvant settingRaquela J Thomas, Eric Bartee
Molecular Therapy Oncolytics|December 18, 2020
Decreasing the Susceptibility of Malignant Cells to Infection Does Not Impact the Overall Efficacy of Myxoma Virus-Based Oncolytic VirotherapyErica B Flores, Eric Bartee
Plos Pathogens|January 24, 2007
Quantitative membrane proteomics reveals new cellular targets of viral immune modulatorsEric Bartee, Ashley McCormack, Klaus Früh
Current Opinion in Microbiology|July 4, 2008
Tumor necrosis factor and interferon: cytokines in harmonyEric Bartee, Mohamed R Mohamed, Grant McFadden
Oncolytic Virotherapy|December 19, 2019
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma VirusChase Burton, Mee Y Bartee, Eric Bartee
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Oncolytic Virotherapy|March 6, 2018
Potential of oncolytic viruses in the treatment of multiple myelomaEric Bartee
Cytokine|July 31, 2009
Human cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-betaEric Bartee, Grant McFadden
Experimental Hematology & Oncology|May 27, 2017
In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockadeEric Bartee, Zihai Li
Cytokine|May 23, 2013
Cytokine synergy: an underappreciated contributor to innate anti-viral immunityEric Bartee, Grant McFadden
Molecular Therapy Oncolytics|January 1, 2020
Syncytia Formation in Oncolytic VirotherapyChase Burton, Eric Bartee
Journal for Immunotherapy of Cancer|April 13, 2022
The use of oncolytic virotherapy in the neoadjuvant settingRaquela J Thomas, Eric Bartee
Molecular Therapy Oncolytics|December 18, 2020
Decreasing the Susceptibility of Malignant Cells to Infection Does Not Impact the Overall Efficacy of Myxoma Virus-Based Oncolytic VirotherapyErica B Flores, Eric Bartee
Plos Pathogens|January 24, 2007
Quantitative membrane proteomics reveals new cellular targets of viral immune modulatorsEric Bartee, Ashley McCormack, Klaus Früh
Current Opinion in Microbiology|July 4, 2008
Tumor necrosis factor and interferon: cytokines in harmonyEric Bartee, Mohamed R Mohamed, Grant McFadden
Oncolytic Virotherapy|December 19, 2019
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma VirusChase Burton, Mee Y Bartee, Eric Bartee
Pageof 5